![]() Adverum Biotechnologies Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases. | |||
Founding Date | Founding Date 2016 | Founding Date 2006 | Founding Date 1995 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Redwood City, US HQ Philadelphia, US | Locations Tampa, US HQ |
Employees | Employees 85 | Employees 11419% increase | Employees 19 |
Valuation ($) | Valuation ($) 159.5 m | Valuation ($) 161.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $19.9m (FY, 2024) | Revenue (est.) $1m (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($131.7m) (FY, 2024) | Net income ($130.9m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 235m | Total funding raised $ 70.7m | Total funding raised $ 16m |

Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
View companyMorphogenesis is a clinical stage company specializing in cell and gene therapies.
View company